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Abstract
DDT1 MF-2 hamster ductus deferens cells are resistant to hypothermia due to serotonin secretion from secretory vesicles
and subsequent cystathionine beta synthase (CBS) mediated formation of H2S. We investigated whether the mechanism
promoting resistance to hypothermia may be translationally induced in cells vulnerable to cold storage. Thus, VMAT-1
(vesicular monoamino transferase) and TPH-1 (tryptophan hydroxylase) were co-transfected in rat aortic smooth muscle
cells (SMAC) and kidney tissue to create a serotonin-vesicular phenotype (named VTSMAC and VTkidney, respectively).
Effects on hypothermic damage were assessed. VTSMAC showed a vesicular phenotype and an 8-fold increase in serotonin
content and 5-fold increase in its release upon cooling. Cooled VTSMAC produced up to 10 fold higher concentrations of
H2S, and were protected from hypothermia, as shown by a 50% reduction of caspase 3/7 activity and 4 times higher survival
compared to SMAC. Hypothermic resistance was abolished by the inhibition of CBS activity or blockade of serotonin re-
uptake. In VTkidney slices, expression of CBS was 3 fold increased in cold preserved kidney tissue, with two-fold increase in
H2S concentration. While cooling induced substantial damage to empty vector transfected kidney as shown by caspase 3/7
activity and loss of FABP1, VTkidney was fully protected and comparable to non-cooled control. Thus, transfection of VMAT-
1 and TPH-1 induced vesicular storage of serotonin which is triggered release upon cooling and has protective effects
against hypothermia. The vesicular serotonergic phenotype protects against hypothermic damage through re-uptake of
serotonin inducing CBS mediated H2S production both in cells and kidney slices.
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Introduction
Hypothermia is potentially harmful to cell viability [1]. DDT1
MF-2 cells (DDT1), which are ductus deferens smooth muscle cells
derived from Syrian golden hamster (Mesocricetus auratus), a natural
hibernating animal, are resistant to hypothermia and do not show
cell death following hypothermia and rewarming of cells in vitro
[2]. We previously found this hypothermic resistance of DDT1
cells to be conveyed by secretion of serotonin from secretory
vesicles in DDT1, and subsequent re-uptake inducing the
formation of H2S through cystathionine beta synthase activation
[2]. One of the effects of hypothermia is membrane depolarization
[3], which would stimulate secretion by secretory cells [4] due to
the activation of voltage-dependent calcium channels, leading to
cell contraction [5]. The storing vesicles in secretory cells contain
different substances including collagen, lipids and neurotransmit-
ters, which are liberated into the medium during secretion [6].
In contrast to DDT1 cells, rat smooth muscle aorta cells (SMAC)
are highlyvulnerableto hypothermic damage[2]. Many celltypes are
vulnerable to hypothermia mainly due to the burst of reactive oxygen
species (ROS) during the re-warming phase leading to low ATP
production, Ca
2+overloadandcellswelling,resultinginapoptoticcell
death [7,8]. Oxidative damage is both present during ischemia/
reperfusion and hypothermia/rewarming [9]. In addition to its
stimulation of H2S production, serotonin attenuates ROS induced
damage through scavenging of ROS [10]. Thus, we hypothesized
that the induction of a serotonergic vesicular phenotype in SMAC
would induce resistance to hypothermia/rewarming damage and cell
death by the activation of a secretory system from vesicular structures
present in cells and subsequent production of H2S.
In our previous study in cells from hibernating animals [2], we
found that cooling induces the release of serotonin. Whether cells
that store dopamine also release this compound upon cooling, is
still unknown. Thus, we chose to induce a vesicular phenotype
containing serotonin. Accordingly, the sequences for TPH-1
(tryptophan hydroxylase-1) and VMAT-1 (vesicular monoamine
transporter-1) were transfected into SMAC and kidney tissue
slices. Different properties in relation to morphology, protein
induction, and cell survival were analyzed after hypothermic
preservation and rewarming. Here we demonstrate that the
introduction of TPH-1 and VMAT-1, representing key compo-
nents of the vesicular serotonergic pathway, leads to hypothermia
induced secretion of serotonin in vitro in SMAC. Further, we
demonstrate that the induction of this vesicular phenotype protects
the integrity of SMAC and of kidney tissue slices in hypothermia/
rewarming damage through the H2S pathway.
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Cell culture
DDT1 MF2 (hamster ductus deferens muscle cells, ATCC, USA
CRL1701) cultured in DMEM (Gibco) and SMAC (rat smooth
muscle aortic cells, ATCC, USA CRL1476) cultured in DMEM/
F12 (Gibco, Belgium) were chosen for this study. The media
was supplied with 10% (v/v%) fetal calf serum and 100 U/ml
penicillin, 100 mg/ml streptomycin and cells were cultured at
37uCi n5 %C O 2 in 25 cm
2 or 75 cm
2 flasks. Morphology of the
cells was performed by phase contrast light microscopic examina-
tion. To study the necessity of the presence of serotonin and CBS
in H2S production and hypothermia resistance, cells were treated
with vehicle, amino oxyacetic acid (AOAA, 10 mM), an inhibitor
of H2S production, or fluoxetine (1 mM), an inhibitor of the
serotonin reuptake. Culture medium was collected after 24h of
hypothermic treatment (3uC).
Quantification of collagen
Picrosirius red was used to quantify the amount of collagen in
cells and the supernatant of cells. To prepare Picrosirius red
solution, 0.2 g Sirius Red F3B was added to 200 ml of saturated
aqueous solution of picric acid. Cells were switched to 5% FBS
medium prior to experiments. Cells at 37uC and at 3uC (18h) were
lysed in RIPA buffer. Duplicate 50 to 100 ml aliquots were added
to 1 ml of dye solution and mixed at room temperature for
30 min, and centrifuged at 10,000 g for 5 minutes to pellet the
collagen. One ml of 0.1 M HCl was added to each tube to remove
unbound dye flowed by centrifugation at 10,000 g for 5 min. One
ml of 0.5 M NaOH was added and vortexed vigorously to release
the bound dye. Absorption was read at 540 nm. Collagen stock
solution (2 mg/ml) was prepared by adding 5 ml of 0.5 M sterile
acetic acid to 10 mg type I Collagen lyophilized powder (Sigma C-
3511). A collagen standard curve was obtained using 12.5 to 75 mg
of collagen [11].
Quantification of serotonin
Ehrlich’s reagent was used to quantify the cellular amount of
indoles [12]. Five ml of medium was shaken vigorously with 2 ml
of xylene. Next, 1 ml of Ehrlich’s reagent was applied to the surface
of the mixture. Redistribution of xylene through the Ehrlich’s
reagent induces formation of the rosindole body, indicating the
presence of indoleamides. To measure the intracellular indole
concentration, cells were washed with PBS, centrifuged (1000 rpm,
5 min) and the supernatant was removed. Four ml of ethyl acetate
was used to extract the serotonin from the supernatant to achieve a
dry extract. Ehrlich reagent (200 ml) was added to either the cell
pellet or the extract. After 3 min of vortexing, tubes were left for 3h
at 60uC and centrifuged (1000 rpm, 5 min). Indole content was
quantified spectrophotometrically at 625 nm. Calibration experi-
ments were carried out using serotonin (0.025–0.5 mM), which
rendered a linear regression with a correlation coefficient (R
2)o f
0.9996 (data not shown).
Constructs
RNA was isolated from brain of male Sprague-Dawley rats
using a nucleospin RNA II kit (Macherey-Nagel, UK) and used for
cDNA synthesis. Sequences were amplified by PCR using primers
designed to produce the full length coding regions. Rat TPH-1
cDNA (1.564 bp) was obtained by amplifying 25 ng of cDNA
using GAACTCCAGTGGCTTTGAGG (forward) and CAGA-
GAGGTGAGAGACATTGCT (reverse) [13]; and for VMAT-1
(1.831 bp) by using 59-CCAGGCAGACTTCTTCTCCTATAA-
A-39 (forward) and 59-GCACTTACAGGTGAGTAAAGGAAA-
GGTA-39 (reverse) [14]. The PCR products were purified by
Nucleospin Extract II (Cat NO. 740609.50, Machery-Nagel,
Netherlands) and size was checked by electrophoresis on a 1.5%
TAE agarose gel at 100V for 20 min (BIO-RAD, PowerPac 300).
The sequences were inserted into pTARGET (Promega, A1410)
and transformed into 5 HD-a E. coli. Plasmid DNA from positive
colonies were isolated (nucleobond PC100, Machery-Nagel,
Netherlands). Correct insertion of the gene was checked by
digestion with EcoRI (Promega, US). The concentration of
plasmid DNA was measured using a NanoDrop spectrophotom-
eter (Life Science ND1000, US).
SMAC transfection with TPH-1 and VMAT-1 plasmids and
protein expression analysis
SMAC were plated in 6 well plates at 50% confluence in
DMEM/F12 medium free of antibiotic and FCS (Gibco, E12-
719F). Plasmids containing the sequences were introduced into the
cells using lipofectamine 2000 according to the manufacturer’s
protocol (Invitrogen, UK). After 24h at 37uC, the supernatant was
replaced with FBS containing normal cell medium and the cells
were left to proliferate for another 24h at 37uC. The double
transfected cells are referred to as VTSMAC (VMAT-1/TPH-1
smooth muscles aortic cells.) Control cells were transfected with
the empty pTARGET vector following the same procedure.
Western blot analysis was performed to investigate the
expression of VMAT-1 and TPH-1 in cells. Cell samples were
homogenized in ice-cold RIPA buffer [15]. Twenty ml of loading
buffer (10% SDS, 50% Glycerol, 0.33 M Tris HCl pH 6.8, 0.05%
bromophenol blue) was added to 50 mg of protein and loaded onto
pre-made gels 4–20% (Thermoscientific 15 wells #25224) for
electrophoresis at 100 V (80 min) and blotting on a nitrocellulose
membrane. VMAT-1 (santa cruz, SC15313) and TPH-1 (santa
cruz, SC30079) specific antibodies (1:1000, overnight at 3uC) were
used to detect these proteins. The membranes were washed three
times with TBS+Tween solution and treated with the related
secondary antibodies (1:1000, 2h at room temperature). The
membranes were developed using super signal West Dura
substrate. Genesnap (Syngene version 6.07) was used to acquire
images and results were analyzed using Genetools version 3.08.
Cell staining and H2S production
For immunohistochemical examination, cells were fixed by
acetone (100%) for 10 min, washed and rehydrated with PBS.
Hydrogen peroxidase activity was blocked by hydrogen peroxide
(1%) in PBS for 30 min, washed with PBS three times for 5 min
each and incubated for 1 h with 1% primary antibody to serotonin
(Abcam, ab8882-50) in PBS containing 1% BSA for 1 h, washed
in PBS thrice and incubated with 1% secondary antibody Goat
AntiRabbit HRP (Dako, po448) in PBS containing 1% BSA for
1 h. The signal was amplified by 1% of a third antibody, rabbit
Anti Goat (Dako, po449) in medium. The slides were washed in
PBS and Dako AEC+High sensitivity substrate chromogen (Dako,
Denmark) was used to visualize the stain. Hematoxyline
counterstaining was performed to visualize the cell nuclei. For
examination of collagen, cells were stained with saturated saffron
(Sigma) solution in 0.07 M borate buffer (pH 10) for 30 min at
room temperature. Staining of VMAT-1 and CBS was performed
using antibodies to VMAT-1 and CBS (santa cruz, sc-46830) in
PBS containing 1% BSA, similar to the procedure with secondary
and tertiary antibodies as described above. The methylene blue
method was used to measure H2S production in 4 ml of cell free
supernatant. Zinc acetate (1%) was added to each sample to trap
the H2S in the supernatant. Diamine-ferric solution was prepared
by mixing 100 ml of a 400 mg N,N-dimethyl-p-phenylenediamine
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ferric chloride in 10 ml 6M HCl. Two hundred ml of this mixture
was added to the sample, incubated for 30 min at 37uC. The
amount of methylene blue was measured at 670 nm [16,17]. The
concentration of H2S was calculated using a methylene blue
standard curve.
siRNA for cystathionine-b-synthase in VTSMAC. The
expression of CBS in VTSMAC was reduced by applying a
predesigned siRNA (sc-60336, Santa Cruz) and compared to a
silencernegativecontrol(Ambion,AM4644).VTSMACcellsat60–
80% confluence were seeded in 96 or 6 well plates in antibiotic-free
normal growth medium supplemented with FCS. Cells were
transfected using lipofectamine 2000 (Invitrogen) at a final
concentration of 100 pmol siRNA in 5 ml lipofectamine for each
well in a 6 well plate and 5 pmol siRNA in 0.25 ml lipofectamine for
each well in a 96 well plate. After 24h, the medium was changed to
the medium containing antibiotics and FCS. Cells were left to
proliferate for 48h at 37uC. Then, control VTSMAC, siRNA
treated VTSMAC and VTSMAC transfected with the negative
control silencer were incubated at 37uCo r3 uC. Cell viability was
measured by MTS assay (Promega). 20 ml of MTS solution was
added to each well and cells were subsequently placed at 37uCi n
5% CO2 for 3h. Absorption was read at 490 nm.
Caspase 3/7 activity and MTS assay
Cells were cultured in a 96 well plate and placed at 37uCf o r4 8 ht i l l
confluence. The cells were treated for 15 min with vehicle, fluoxetine
(1 mM) or AOAA (10 mM) and then placed at 3uC for 24h. Caspase
3/7 activity was measured by adding 50 mlo fA p o - O N E H Homo-
geneous Caspase-3/7 reagent (G7792, Promega, Germany) after
shaking for 3h. Fluorescence was read at an excitation of 499 nm and
emission of 521 nm. Cell viability was measured by MTS assay.
Kidney slice transfection with TPH-1 and VMAT-1
plasmids
Kidneys were surgically removed from two male Sprague-
Dawley rats (450 g) after euthanization under isoflurane anesthe-
sia, flushed with ice cold PBS and cut into 3 millimeter thick
sections. Slices immediately deep frozen or fixed in a zinc fixative
solution (0.1 M Tris-HCl pH 7.8, 0.05% calcium acetate, 0.5%
zinc acetate, 0.5% zinc chloride) served as 37uC control. The
TPH-1 and VMAT-1 or empty vectors were transfected into the
remaining slices using Lipofectamine-2000 (Invitrogen) at 10 ng/
ml for each vector in 300 ml of DMEM-MF12 medium without
FBS at 37uC for 18 h. Then, medium was changed to DMEM
supplemented with 10% FCS and 100 U/ml penicillin, 100 mg/ml
streptomycin. Thereupon, the tubes were transferred to 3uC for
24h following 1 hr of rewarming at 37uC. The animal experiment
was approved by the Animal Experiments Committee of the
University of Groningen, The Netherlands (DEC#5920).
Tissue damage in kidney after tranfection and NaHS
treatment
We have previously shown that NaHS protects SMAC against
hypothermia rewarming injury [2] to further compare the
protective effects of TPH-1 and VMAT-1 transfection to the direct
effects of NaHS addition to kidney medium. For this purpose,
untreated kidney slices that were cooled for 24h at 3uC were treated
with sodium hydrosulfide (NaHS, 0.3 mM) immediately before
rewarming, to assure the presence of H2S during rewarming. Non-
treated kidney slices served as controls. Caspase 3/7 activity,
western blotting and immunohistochemistry were used. Caspase
activity was measured in 500 mg of protein from tissue lysed in
50 mM potassium phosphate buffer (pH 6.9, 5%, w/v), sodium
orthovanadate 10 mM and protease inhibitor (50 ml). Fifty mlo f
substrate (Promega Apo-ONEH) was added and shaken for 3h.
Expression of Fatty Acid Binding Protein1 (FABP1) was used to
detect ischemic kidney injury [18]. Kidney samples were
homogenized in ice-cold RIPA buffer. 50 mg of protein was
loaded onto pre-made gels and the process of western blotting was
followed as previously described. FABP1 was detected using a
specific antibody (1:1000; Santa Cruz, SC50380) followed by a
secondary antibody. The bands were detected as previously
described for VMAT-1 and TPH-1.
For immunohistochemistry, samples were fixed and embedded
in paraffin, cut in 3 mm sections, deparaffinized and submitted to
antibody staining for VMAT-1, CBS, and FABP1. Sections were
incubated with primary antibodies (1:100) with 1% BSA for 1 hr
and subsequently washed three times with PBS. Next, sections
were incubated with secondary antibodies (1:100) with 1% BSA
and 1% rat serum for an hour and subsequently washed 3 times
with PBS. A fluorescent second antibody (1:100) with 1% BSA and
1% rat serum was added against FABP1 antibody. For all the
stains except FABP1 Dako AEC was used to visualize the primary
antibody and hematoxyline counterstaining was performed to
visualize the cell nuclei. Dako fluorescence mounting medium+-
DAPI was used to visualize FABP1 stains.
H2S production in kidney
Pieces of kidney were homogenized in ice-cold 50 mM potassium
phosphate buffer, pH 8.0 (12% wt/vol) on dry ice. The homogenate
was centrifuged (47,000 g; 10 minutes; 4uC) and the supernatant
(75 ml), mixed with 0.25 ml Zn acetate (1%) and 0.45 ml water for
10 minutes at room temperature. TCA (10%; 0.25 ml) was then
added and centrifuged (14.000 g;1 0 m i n u t e s ;4 uC). The clear
supernatant was mixed with N,N-dimethyl-p-phenylenediamine
sulfate (20 mM; 133 ml) in 7.2 M HCl and FeCl3 (30 mM; 133 ml)
in 1.2 M HCl. After 20 minutes, absorbance was measured at
670 nm. Blanks were made following the same procedure without
samples.TheconcentrationofH2Swascalculatedasoutlinedabove.
Statistics
Data are presented as mean 6 SEM. Statistical data analyses
were performed using a One-way ANOVA (P,0.05) with Tukey
post-hoc testing (GraphPad Prism version 5.00 for Windows,
GraphPad Software, San Diego California USA), unless indicated
otherwise.
Results
VTSMAC microscopy
SMAC were studied at 48h after transfection with both TPH-1
and VMAT-1 or empty vector. The transfected SMAC were
named VTSMAC (Fig.1 B). VTSMAC demonstrated a higher
number of cellular vesicles (Fig.1 B1) compared to SMAC (Fig.1
A1), very similar to those found in DDT1 (Fig.1 C1). Serotonin
antibody stain showed the presence of serotonin as red dots in
VTSMAC, primarily localized at the nucleus (Fig.1 B2), which was
similar to DDT-1 (Fig.1 C2), while SMAC lacked their presence
(Fig.1 A2). Transfection with TPH-1 and VMAT-1 yielded a
typical transfection efficiency of 65% as measured by serotonin
antibody staining and counting of cells that expressed intracellular
serotonin after transfection. The expression of VMAT-1 and
TPH-1 proteins after transfection were measured using western
blot analysis. VTSMAC displayed a significant upregulation of
VMAT-1 protein levels compared to control SMAC and empty
vector transfected cells (Fig.1 D). Similar results were observed for
TPH-1 protein (Fig. S1A).
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yellowish coloring in VTSMAC (Fig.1 B3), with higher intensity
compared to SMAC (Fig.1 A3), and at similar levels as found in
DDT1 (Fig.1 C3). CBS antibody stain demonstrated the presence
of this protein inside the VTSMAC. CBS protein was localized in
cytoplasmic and nuclear compartments (Fig.1 B4). CBS protein
was also observed in SMAC (Fig.1 A4) and DDT1 (Fig.1 C4).
Serotonin and collagen concentration
The intracellular concentration of serotonin in VTSMAC was 5
times increased compared to SMAC, and ranged up to 2/3 of the
concentration measured in DDT1 cells (Fig. 2A). Similarly to
DDT1 cells, the concentration of serotonin in the supernatant of
the VTSMAC after 18h of hypothermia treatment at 3uC
increased 6 fold, while no increase was found in supernatant of
cooled SMAC (Fig. 2B). The concentration of collagen in the
supernatant of the VTSMAC after 18h of hypothermia treatment
at 3uC increased 5 fold (Fig. 2C). While a similar increase was
observed in hypothermic DDT1 cells, cooling of SMAC did not
induce an increase of the collagen concentration of supernatant
(Fig. 2C). Collectively, the above data demonstrate that VTSMAC
display a serotonin vesicular phenotype.
Hypothermia resistance of VTSMAC involves serotonin
and H2S
Caspase 3/7 activity in cells was investigated as an apoptotic
marker before and after hypothermia treatment of VTSMAC,
SMAC and DDT1 (Fig. 2D) in cells cooled for 24h and re-warmed
Figure 1. Co-expression of rat tryptophan hydroxylase-1 (TPH-1) and vesicular monoamine transporter-1 (VMAT-1) in smooth
muscle aorta cells (SMAC) induces a serotonergic vesicular phenotype. Effects are compared between aortic cells transfected with empty
vector (SMAC), with vectors containing coding sequences (VTSMAC) and natural resistant DDT1 cells. A to C, microscopic evaluation demonstrating
the presence of vesicles (subpanels 1), antibody staining reveals the presence of mainly nuclear serotonin (subpanels 2), collagen (subpanels 3) and
CBS (subpanels 4) in VTSMAC and DDT1, whereas expression is absent or lower in SMAC. Original magnification 40x. D, VMAT-1 expression is
increased in VTSMAC compared to SMAC. The data are Mean 6 SEM (n=3); p,0.005; ANOVA.
doi:10.1371/journal.pone.0030400.g001
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to 37uC control cells, while cooled SMAC showed a significant
increase in caspase 3/7 activity (Fig. 2D). The viability of
VTSMAC was verified by MTS assay after incubation of the
cells for 24h at 3uC and rewarming for 3h. Whereas 80% of
VTSMAC survived the cooling/rewarming compared to non-
cooled VTSMAC, survival in untransfected SMAC amounted
only 30% (Fig. 2E). Further, DDT1 cells showed full survival of
cooling and ewarming. CBS SiRNA almost completely downreg-
ulated CBS expression (Fig. S1). Cell survival in VTSMAC was
decreased by treatment with fluoxetine and AOAA (aminooxy
acetic acid), an inhibitor of CBS activity and by siRNA against
CBS. DDT1 cell survival was mainly affected by fluoxetine
(Fig. 2E).
H2S has been shown to exert protective effects in hypothermic
damage of SMAC. To verify the hypothesis that VTSMAC show
resistance to cooling because of H2S production, its concentration
was measured in the absence and presence of fluoxetine or AOAA.
Cooling at 3uC for 18h induced a 7–10 fold increase in the H2S
concentration present in the supernatant of VTSMAC, while its
Figure 2. The serotonin vesicular phenotype protects VTSMAC from hypothermic damage through serotonin reuptake and CBS
mediated production of H2S. A, cellular levels of serotonin are increased in VTSMAC compared to SMAC at 37uC and decrease upon cooling. B,
Upon cooling, serotonin is released from VTSMAC and DDT1 as demonstrated by increased levels of serotonin in the supernatant. C, release of
collagen in the supernatant upon cooling in VTSMAC and DDT1. D, caspase 3/7 activity is normalized in VTSMAC compared to SMAC following
hypothermia. E, MTS assay shows increased survival of VTSMAC after 24h at 3uC compared to control SMAC. The augmentation of cell survival in
VTSMAC is abrogated by treatment with AOAA (10 mM), fluoxetine (1 mM) or SiRNA against CBS. F, H2S content of supernatant of cells following
cooling (24h, 3uC). VTSMAC show increased H2S levels compared to SMAC, which is inhibited by AOAA and fluoxetine. Gray bars represent controls in
each cell line (37uC) and black bars represent cells after static hypothermic storage (3uC, 24h). * represent significant difference to control bars in each
group. The data are Mean 6 SEM (n=3); p,0.005; ANOVA.
doi:10.1371/journal.pone.0030400.g002
Vesicular Phenotype Protects against Cell Death
PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e30400concentration in SMAC was unchanged (Fig. 2F). Both fluoxetine
and AOAA drastically reduced the content of H2S in the
supernatant of all cells. DDT1 showed less inhibition of H2S
production by either substance compared to both SMAC and
VTSMAC (Fig. 2F).
Taken together, these data imply that in VTSMAC, re-uptake
of serotonin results in the production of H2S through CBS, in turn
protecting cells against hypothermia/rewarming damage.
Kidney transfection with TPH-1 and VMAT-1 attenuates
hypothermic damage
To assess the potential of VMAT-1 and TPH-1 transfection in
protecting kidney tissue against hypothermia/rewarming damage,
kidney slices were transfected with TPH-1 and VMAT-1
(VTkidney) or empty vector. The success of the transfection was
assessed through VMAT-1 antibody staining and immunoblot
analysis. The intensity of the VMAT-1 stain increased in kidneys
transfected with VMAT-1 and TPH-1 compared to empty vector,
mainly in tubular cells (Fig. 3A). Immunoblotting showed a
doubling of the expression of VMAT-1 (Fig. 3A) and TPH-1 (Fig.
S1B) in VTkidney compared to control tissue.
Hypothermic storage downregulated FABP1 expression by 50%
(Fig. 3C) and doubled activity of caspase 3/7 (Fig. 3D) in empty
vector treated tissue. In contrast, in VTkidney and NaHS treated
kidney slices, caspase activity and FABP1 expression was
unaffected by hypothermic storage and maintained at control
levels.
To substantiate involvement of the H2S system, CBS expression
in kidney slices was measured by western blotting and immuno-
histology. In VT kidney following hypothermic storage, CBS
expression was doubled compared to empty vector transfected
tissues, which show lower expression of CBS compared to 37uC
controls (Fig. 3B). The same was observed in immunostaining, in
which CBS was mainly present in the endothelium and the
epithelium of kidney glomeruli and in the tubuli (Fig. 3B). Finally,
H2S concentration was more than doubled in transfected tissue
compared to controls (Fig. 3E).
Thus, VTkidney slices show an increase in the expression of
VMAT-1 and CBS, increased production of H2S, and attenuation
of renal damage following hypothermia/rewarming, as evidenced
by maintained FABP1 staining and normalized caspase 3/7
activity.
Discussion
This is the first account of cells becoming resistant to
hypothermia rewarming damage after the induction of a vesicular
serotonergic phenotype, as accomplished by transfection with
TPH-1 and VMAT-1. Induction of the serotonergic vesicular
phenotype was shown by increased staining for serotonin and
increased expression of VMAT-1 and TPH-1. Resistance to
hypothermia (3uC) and rewarming (37uC) in transfected smooth
muscle aorta cells, named VTSMAC, was demonstrated by
reduced apoptosis and increased viability of cells. Further, as
shown previously in DDT1 cells, which show natural resistance to
hypothermia [2] the resistance of VTSMAC to hypothermia was
also mediated by CBS dependent production of H2S following the
induction of the vesicular serotonergic phenotype. In addition,
transfection of kidney slices with vectors containing TPH-1 and
VMAT-1 sequences increases their viability after hypothermic
storage, as demonstrated by a normal level of caspase 3/7 activity
and FABP1 expression. Further, kidney tissue transfected with
plasmids containing TPH-1 and VMAT-1 sequences showed
increased production of H2S, which is in accordance with the
observed increase in CBS expression. NaHS treatment of kidney
slices showed similar results as transfection with TPH-1 and
VMAT-1, with decreased damage evidenced by lower caspase
activity and increased FABP1 expression. From these data we
conclude that while the use of NaHS constitutes a novel nongenetic
strategy to protect cells and organsagainst hypothermia/rewarming
injury, the induction of a serotonergic vesicular phenotype
represents a novel genetic strategy to protect against this damage.
We demonstrate the successful induction of a vesicular,
serotonergic phenotype in VTSMAC, as evidenced by an increase
in the production and storage of serotonin in cells. We observed
the presence of vesicles in VTSMAC very similar to those
observed in DDT1. Increased levels of compounds such as
collagen and serotonin was found in medium in response to
hypothermia treatment both in DDT1 and VTSMAC, further
substantiating that hypothermia triggers the secretion from cellular
vesicles. Apart from the secretion of serotonin, our study also
identifies hypothermia to cause secretion of collagen from
VTSMAC and DDT1, which is related to the vesicular phenotype
as there is limited secretion from non-transfected SMAC without
vesicles.
Similarly to DDT1 cells, hypothermic treatment of VTSMAC
induces the release of serotonin from the vesicular system.
Apparently, the re-uptake of serotonin is a crucial step in governing
protection, as the protection from hypothermic damage was
abrogated by inhibition of serotonin reuptake following treatment
of VTSMAC with a SSRI such as Fluoxetine. While serotonin itself
has antioxidant properties [19], the protection of VTSMAC against
hypothermia/rewarming damage is likely due to the production of
H2S, as the protective effect was annihilated by the CBS inhibitor
AOAA and CBS siRNA. The mechanism we previously identified
[2] is based on serotonin preventing hypothermia/re-warming
induced cell apoptosis by increasing H2S formation through CBS
upregulationandprobably allostericactivation. The upregulationof
CBS seems however independent of 5-HT receptor activation, as
serotonin effect was unaffected by the non-selective 5-HT receptor
antagonist, ketanserine. [2]. The precise mechanism of CBS
upregulation following serotonin reuptake remains to be elucidated.
Thus, VTSMAC gain phenotypical characteristics and display
resistance against hypothermic induced cell death similar to DDT1
cells. Our findings are in line with the protective effect of serotonin
treatment in SMAC [2].
Our results demonstrate that the induction of a vesicular
serotonergic phenotype also protects kidney tissue, as evidenced by
increased cell survival following cold static storage. Likely, the
mechanism of protection is similar to those of VTSMAC, in view
of the increased expression of CBS and increased H2S levels in
hypothermia preserved kidney tissue transfected with TPH-1 and
VMAT-1. The protection from hypothermic kidney damage by
serotonin is in line with data showing protection in transplanted
kidney by the bioamine dopamine [20].
Increased production of H2S is likely to represent the leading
mechanism in the protection of TPH-1 and VMAT-1 transfected
cells and tissues against hypothermic damage. Hypothermia
damage to cells has been hypothesized to be mainly due to a
burst of reactive oxygen species (ROS) upon rewarming.
Particularly during the rewarming phase, low ATP production,
Ca
2+ overload and cell swelling result in apoptotic cell death. The
presence of oxidative damage is regarded the most important
adverse event following hypothermia/rewarming [7,21]. The
exogenous administration of H2S, either as a gas or as a salt,
has been found to limit cell death in different in vitro models from
ROS associated cell damage, such as ischemia-reperfusion injury
of myocardium [22], kidney tissue [23], epithelial cells [24] and
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30400Figure 3. Co-expression of rat vesicular monoamine transporter-1 (VMAT-1) and tryptophan hydroxylase-1 (TPH-1) in kidney slices
(VTkidney) and treatment of kidney slices with NaHS (0.3 mM) protect tissue against static hypothermic storage (36C, 24h) by
induction of cystathionine beta synthase (CBS) and H2S production. A, VTkidney show increased expression of VMAT-1. B, VTkidney shows
increased expression of CBS, with main presence in tubular cells. C, VTkidney and NaHS treated slices show absence of hypothermia induced loss of
fatty acid binding protein (FABP1). FABP1 staining (green) was predominantly in the cytoplasmic region of the proximal tubule. D, VTkidney and
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30400liver cells [3]. Further, H2S has been shown to directly scavenge
free radicals [25]. We previously showed increased production of
endogenous H2S to protect cells from hypothermic damage and
identified CBS as the main enzyme involved [2]. This mechanism
is likely to convey the protective effect of TPH-1 and VMAT-1
expression both in cells and tissue, in view of its abrogation of by
the CBS inhibitor AOAA. Involvement of CBS is the more likely,
as the enzyme is downregulated by hypothermic storage as found
by us and previously in rat kidney [26]. Our data show that
expression of CBS is restored both in transfected cells and tissue.
While we demonstrate H2S production through CBS after the
induction of a serotonergic vesicular phenotype in kidney to be a
protective factor against hypothermia, others have implicated CSE
(cystathionine gamma lyase) as the principal H2S producing
enzyme in the kidney with protective properties against ischemia
reperfusion damage [16]. In our experiments we found only CBS
to be implicated in protection against hypothermia-rewarming
induced damage, as demonstrated by the attenuation of protection
by specific CBS siRNA knockdown and by treatment with AOAA.
Further, we did not find a significant change in the expression of
CSE following serotonin treatment (data not shown). Exploiting
the beneficial effects of production and storage of serotonin and
the consequent release and production of H2S through an internal
source is possibly one of the most strategic manipulations to
consider when protection against hypothermia induced ischemia
reperfusion is concerned. There is, however, few or no relevant
data on ischemia/reperfusion or hypothermic injury being
suppressed through the induction/presence of a vesicular
phenotype which stores a protective molecule such as serotonin,
while having the characteristic to be triggered release due to
hypothermia and finally to induce the production of endogenous
H2S through CBS.
In summary, H2S protects against hypothermia damage and the
transfection with TPH-1 and VMAT-1 induces production and
storage of serotonin in cultured cells and renal tissue, which upon
release and re-uptake conveys resistance to hypothermia via the
induction of H2S production through CBS. This finding may serve
to develop novel strategies to improve viability of transplantation
organs based on the induction of a triggered release system in cells
where vesicular entities store and release a protective factor such as
serotonin. Further, it contributes to understanding the importance
of the presence and the role of a vesicular phenotype in protection
of cells against a damaging stress such as hypothermia.
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Figure S1 TPH-1 protein expression increases in SMAC
and kidney slices after transfection with TPH-1 and
VMAT-1 sequences (transfected cells/tissue is referred
to as VTSMAC and VTkidney). A) TPH-1 expression in
VTSMAC increases two fold compared to SMAC, B) TPH-1
expression in VTkidney increases two fold compared to normal
kidney. Data are mean 6 SEM (n $3 per group). * different to
normal cells, P,0.05.
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